Search results for: 'ICT Market Forecast'
- Related search terms
- marketing strategy hotel industry year 1999
- marketing strategy homes industry year 16.9
- marketing strateg homes industry year 1.09
- market analyst of rf energy harvesting technolog
- marketing strategy homes industry yeast 1.09
-
03 Feb 2021  |  North America  |  Market Research
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Jun 2021  |  North America  |  Market Research
US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities
Telegenetic Counseling to Revolutionize Access to Patient Care
In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...
$2,450.00
Special Price $1,837.50 save 25 %
-
16 Feb 2021  |  North America  |  Market Research
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market
Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care
Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...
$2,450.00
Special Price $1,837.50 save 25 %
-
08 Oct 2021  |  North America  |  Market Research
Global Tissue Diagnostics (TDx) Growth Opportunities
Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma
This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Dec 2020  |  North America  |  Market Research
Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020
Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity
The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00
Special Price $1,837.50 save 25 %
-
11 Dec 2020  |  North America  |  Market Research
COVID-19 Pandemic Catalyzes the Transformation of the In-vitro Diagnostics Industry
Future Growth Potential is Enriched by Alternate Testing Sites in the Point-of-Care Testing Segment
This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...
$2,450.00
Special Price $1,837.50 save 25 %
-
12 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jun 2024  |  Global  |  Market Research
Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029
A Steady Increase in Laboratory Budgets in Academia is Driving Innovation
This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00
Special Price $3,712.50 save 25 %